Everest Medicines Limited (FRA:6HN)
Germany · Delayed Price · Currency is EUR 4.480
+0.360 (8.74%)
At close: Jan 23, 2026
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of €1.48 billion as of January 30, 2026. Its market cap has decreased by -15.39% in one year.
Market Cap
1.48B
Enterprise Value
1.38B
Revenue
101.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.48
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 2.25B to 1.48B, a decrease of -34.18%. That is a compound annual growth rate of -7.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.48B | 3.77% |
| Dec 31, 2025 | 1.43B | -26.27% |
| Dec 31, 2024 | 1.94B | 150.05% |
| Dec 29, 2023 | 775.42M | 20.25% |
| Dec 30, 2022 | 644.85M | -44.62% |
| Dec 31, 2021 | 1.16B | -44.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.48B |
| Mainova AG | 2.45B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.19B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Northern Data AG | 842.90M |